Dear colleagues and friends,
The first Post-Chicago Meeting on Melanoma / Skin Cancer took place 2011. In 2019, the meeting has attracted more than 700 participants. In 2022 the meeting was held as hybrid meeting with more than 400 attendees on site and another 500 virtually. The interactive congress offers a comprehensive overview on all new developments in melanoma diagnostics and therapy and a direct communication with the world’s leading experts in these fields.
The aim of the Interdisciplinary Global Conference on News in Melanoma/ Skin Cancer in Munich is to grant a deep overall insight into the development of new drugs for melanoma and other cutaneous malignancies. The lively interaction of clinicians, as well as experts in translational and basic research, and representatives of the pharmaceutical industry, guarantees a successful outcome for every participant.
International key opinion leaders on melanoma will be invited to give an overview throughout specified presentations, to present latest clinical trial results, and to discuss on exciting new drugs with the audience. In addition to the scientific value of this meeting, every participant may seize the given opportunity to interact with experts in a familiar setting in one of the most interesting cities of Germany.
We look forward to welcoming you in Munich in June 2023!
Axel Hauschild. MD
Congress President
Claus Garbe, MD
Congress President